Select Reports

Oxford Gene Technology Grants Microarray Licence to BF-BIOlabs
The granted licence will enable BF-BIOlabs to sell arrays and provide services that include the design and production of custom-made microarrays.

Children’s Hospital of Pittsburgh Researchers Identify Genetic Mutation that may Predict Organ Rejection
Using a combination of technologies to scan the human genome, researchers have identified a genetic mutation that identifies transplant recipients who experience rejection.

Applied Biosystems Launches Service Provider Programme for Real-Time RNA Expression Analysis
Nine organisations are named as service providers for RNA expression analysis.

Gene Expression Study to Develop Prognostic Test for Early Non-Small Cell Lung Cancer
Almac Diagnostics has announced details of a global multi-centre collaborative lung cancer study with leading research organisations in the USA, Canada, Asia and Europe.

febit and TGen Collaborate to Study New DNA Capture Method
febit’s HybSelect™ technology evaluated to enable targeting and increase speed for next-generation-sequencing.

NHGRI Seeks DNA Sequencing Technologies Fit for Routine Laboratory and Medical Use
The Institute has awarded more than $20 million in grants to develop inexpensive sequencing technologies to sequence a person's DNA as a routine part of biomedical research.

BioNanomatrix Awarded NIH Grant for Development of Nanoscale Platform
Goal is development of a fully integrated nanochannel chip and reader for single-molecule mapping.

TOWARDS MULTI-ANALYTE BIOSENSOR FOR FOOD SCREENING BASED ON IBIS IMAGING SPR
Wageningen University and Research centrum (WUR)

Our aim is to develop a dedicated tool for multi-analyte detection in food based on IBIS Surface Plasmon Resonance imaging platform using a microarray format. Utilizing a multi-immunoassay on top of the SPR- imaging platform will allow rapid and simultaneous detection of various food ingredients and contaminants (e.g. food allergens, residues of veterinary drugs and environmental contaminants), providing the end user with a detailed food profile.

Combination of a transient assay based ChIP technology and transcriptome analyses for the exploration of potential transcription factor binding sites
Institute of Plant and Microbial Biology, Academia Sinica

1. Combination of protoplast transient expression system and Nickel resin based purification is an useful approach for chromatin enrichment that can be used to identify transcription factor’s potential target genes. 2.Comparison our ChIP-on-chip target genes with in vivo binding targets using two whole genome tiling array platforms showing high degree of overlap between two methods.

Phase Diagram Visualization via Continuously-Fed Crystallization: Experiments and Model
University of Minnesota

A continuously-fed crystallization chamber is manufactured to allow phase diagram visualization. This microfluidic system allows the experimenter to screen a large range of salt and protein concentrations in one experiment. This allows the experimenter to predict the protein phase diagram in a single experiment. A continuous-feed crystallization chamber has been successfully fabricated and characterized in terms of its flow profile, and has successfully predicted the phase diagram for lysozyme.

Quality Systems Co-ordinator
Select Biosciences Recruitment
UK

Process Development Manager
Select Biosciences Recruitment
UK

Research Scientist
Select Biosciences Recruitment
UK

Chemistry Product Sales Specialist
Select Biosciences Recruitment
UK

Business Development Professionals
Select Biosciences Recruitment
UK

Project Manager
Evolution Life Science
South East, UK

Sales Specialist
Evolution Life Science
Cambridge/East Midlands, UK

Bioanalytical Scientist
Evolution Life Science
North West, UK

European Biomarkers Summit, Lisbon, Portugal
16 October 2008 - 17 October 2008

Welcome to the 3rd annual European Biomarkers Summit. This year's event will take place in the historic city of Lisbon.

The conference will be co-located with Advances in Metabolic Profiling and Proteomics Europe. Registered delegates will have access to all three meetings ensuring a very cost-effective trip.

Proteomics Europe, Lisbon, Portugal
16 October 2008 - 17 October 2008

This year’s conference will address Protein Arrays and their Applications, Protein Expression, High Throughput Proteomics, Bioinformatics and Disease-Related Proteomics. The conference will include a keynote address from Dolores Cahill, University College Dublin. Registered delegates will enjoy free access to the co-located conferences Advances in Metabolic Profiling and European Biomarkers Summit.

Pittcon 2009, Chicago, IL, USA
08 March 2009 - 13 March 2009

The premier conference and exposition on laboratory sciences celebrates 60 years of service to the scientific community. Pittcon is the most comprehensive annual meeting on laboratory science in the world, offering a first class lab product exposition, a diverse, high quality technical program, unparallelled educational programs, and invaluable peer to peer networking opportunities.
  
Validation of Protein Biomarkers in Tissue Arrays

William Gallagher, Associate Professor of Cancer Biology, University College Dublin, speaking at Cancer Proteomics 2007
Immune Response and Biomarker Profiling Using Human Protein Microarrays

Michael Smith, Scientist, Invitrogen, speaking at Cancer Proteomics 2007
Low Input Array Comparative Genomic Hybridization

Steven Roman, Senior Scientist, Invitrogen Corporation, speaking at Advances in Microarray Technology 2007

Multiplexed Diagnostics 2008 Market Report
Published May 2008

Multiplexed diagnostics are the wild west of medicine. Technology is established, regulation is limited and the number of new biomarkers exploding. First-movers are grabbing biomarker territories, combining independent measurements for efficiency and mining molecules for multivariate panels. All the while demand is high for improving diagnoses and predicting responses to treatment. The challenges, however, are uncertain reimbursement, unclear business models and ever-intensifying competition. On

Epigenetics and MicroRNA Diagnostics/Therapeutics 2008 Market Report
Published May 2008

Epigenetics is undergoing a massive industry expansion and this report focuses in on the science, market, and therapeutics trends in this emerging area. Select Biosciences proprietary market analyses addressed the qualitative and quantitative trends in the epigenetics marketplace focusing on the technology trends, market trends, and therapeutics space.

Emerging Markets for Microfluidic Applications
Published May 2007

Drug discovery remains today the first microfluidics market. Microfluidics key advantage is to enable higher analysis throughput while decreasing analysis time and cost. Firstly used at the system level for liquid handling, microfluidics technology is also successfully integrated in cartridges for research applications.